News Chong Kun Dang Pharmaceutical Corp.

Equities

A185750

KR7185750007

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
103,200 ^KRW	+0.58%		-0.29%	-21.16%

04-25	Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024.	CI
01-23	Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024.	04-25	CI
Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares.	01-23	CI
Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan.	01-22	CI
Chong Kun Dang Pharmaceutical Inks Largest-Ever Technology Transfer Agreement with Novartis	11-08	MT
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.	23-10-16	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.	23-10-16	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.	23-10-16	CI
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on October 13, 2022, has expired with 62,127 shares, representing 0.51% for KRW 4,856.39 million.	23-10-15	CI
Chong Kun Dang Pharmaceutical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.	23-02-14	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.	23-02-14	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.	23-02-14	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.	23-02-14	CI
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on February 10, 2022, has expired with 109,064 shares, representing 0.89% for KRW 9,895.01 million.	23-02-09	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.	23-01-18	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.	22-10-19	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.	22-10-19	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.	22-10-19	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.	22-10-19	CI
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.	22-10-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chong Kun Dang Pharmaceutical Corp.

Equities

A185750

KR7185750007

Summary

Filters